Funded Artificial Intelligence Startups in Poland
The 26 rows in this dataset span rounds closed between September 2020 and June 2025, with Warsaw (Mazowieckie) accounting for roughly half the companies —…
The 26 rows in this dataset span rounds closed between September 2020 and June 2025, with Warsaw (Mazowieckie) accounting for roughly half the companies — including Nomagic, neptune.ai, Nethone, ReSpo.Vision, and Saventic Health. Kraków and Wrocław each host four companies, while Poznań contributes three.
The largest disclosed transaction is Nomagic's $44M Series B in February 2025, a robotics-AI play that sits well above the rest of the set. Infermedica's $30M Series B from January 2022 is the second-largest. Healthcare applications appear repeatedly — Aether Biomedical ($6M Series A), MIM Fertility ($2M Seed), Cardiomatics ($3M Seed), and Saventic Health — alongside developer-tooling companies like neptune.ai ($8M Series A) and fraud-detection specialist Nethone ($7M Series A). Eight entries carry a "Series Unknown" label spanning check sizes from $740K to $5M, so stage-based filtering on this segment requires caution.
Most recent rounds
26 shownRelated listings
Frequently asked
What are the largest disclosed rounds among Polish AI startups in this data?
Nomagic leads with a $44M Series B closed in February 2025, followed by Infermedica's $30M Series B in January 2022. The next tier includes Synerise at $9M (Series B, July 2024), neptune.ai at $8M (Series A, April 2022), and Aether Biomedical at $6M (Series A, November 2023).
Which cities concentrate the most AI startup funding activity in Poland?
Warsaw (Mazowieckie) accounts for roughly half the companies in the dataset, including Nomagic, ReSpo.Vision, neptune.ai, Nethone, and Saventic Health. Kraków and Wrocław each appear four times — Kraków with Synerise and Cardiomatics, Wrocław with Infermedica and NeuroSYS. Poznań contributes three companies: Aether Biomedical, AGICortex, and FitMech.
Is healthcare a significant vertical within Polish AI funding?
At least five companies in the dataset target health or life sciences: Infermedica ($30M Series B), Aether Biomedical ($6M Series A), MIM Fertility ($2M Seed), Saventic Health, and Cardiomatics ($3M Seed). Rounds in this sub-vertical span from August 2021 through December 2024, indicating sustained rather than episodic investor interest.
What stage do most Polish AI companies reach before raising a disclosed round?
"Series Unknown" is the most frequently tagged label, appearing eight times — ranging from Molecule.one at $1M to edrone at $5M — which limits clean stage-level comparisons. Among labeled rounds, Seed appears seven times and Pre-Seed three times. Only three companies in the set have reached Series B: Nomagic, Synerise, and Infermedica.
What check sizes should sales or investors expect at early stages in this market?
Seed rounds in this dataset range from $100K (STERNKRAFT, March 2022) to $5M (ReSpo.Vision, June 2025), with most clustering between $700K and $3M. Pre-Seed checks run from $300K (AGICortex) to $2M (Epinote). Two rounds — SATIM and Digimans.ai — are listed with undisclosed amounts.
Has deal flow for Polish AI startups accelerated or slowed in recent years?
Based on the 26 rows shown, 2023 had the highest density with eight rounds, while 2024 produced four and 2025 has recorded three through mid-June. The pattern suggests a post-2023 moderation in volume, though Nomagic's $44M Series B in February 2025 marks the largest single transaction in the entire set.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.